Omada Health (OMDA) Liabilities and Shareholders Equity (2024 - 2026)

Omada Health has disclosed Liabilities and Shareholders Equity across 3 years of filings, most recently posting $328.2 million for Q2 2026.

• In Q2 2026, Liabilities and Shareholders Equity rose 8.33% year-over-year to $328.2 million; the TTM figure through Jun 2026 stood at $1.2 billion (up 169.66% YoY), while the FY2025 annual figure was $305.4 million, up 102.4% from the prior year.
• Liabilities and Shareholders Equity came in at $328.2 million for Q2 2026 at Omada Health, up from $302.8 million in the prior quarter.
• In the past five years, Liabilities and Shareholders Equity ranged from a high of $328.2 million in Q2 2026 to a low of $150.9 million in Q4 2024.
• Average Liabilities and Shareholders Equity over 3 years is $279.6 million, with a median of $302.9 million recorded in 2025.
• Year-over-year, Liabilities and Shareholders Equity soared 102.4% in 2025 and rose 8.33% in 2026.
• Over 3 years, Liabilities and Shareholders Equity stood at $150.9 million in 2024, then surged by 102.4% to $305.4 million in 2025, then rose by 7.47% to $328.2 million in 2026.
• Per Business Quant data, the three most recent Liabilities and Shareholders Equity figures were $328.2 million in Q2 2026, $302.8 million in Q1 2026, and $305.4 million in Q4 2025.